Donation after circulatory death (DCD) procurements provide an opportunity to alleviate the limited organ supply for solid ...
Researchers found that lecanemab, the Alzheimer’s drug designed to clear amyloid-β plaques, does not improve the brain’s waste clearance system in the short term.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback